These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 17699459

  • 1. Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes.
    Burroughs TE, Lentine KL, Takemoto SK, Swindle J, Machnicki G, Hardinger K, Brennan DC, Irish WD, Schnitzler MA.
    Clin J Am Soc Nephrol; 2007 May; 2(3):517-23. PubMed ID: 17699459
    [Abstract] [Full Text] [Related]

  • 2. Diabetes mellitus after kidney transplantation: a French multicentre observational study.
    Kamar N, Mariat C, Delahousse M, Dantal J, Al Najjar A, Cassuto E, Lefrançois N, Cointault O, Touchard G, Villemain F, Di Giambattista F, Benhamou PY, Diapason Study Group.
    Nephrol Dial Transplant; 2007 Jul; 22(7):1986-93. PubMed ID: 17400559
    [Abstract] [Full Text] [Related]

  • 3. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
    Yu X, Zhang B, Xing C, Sun B, Liu M, Zhang W, Gu M.
    Transplant Proc; 2008 Dec; 40(10):3455-9. PubMed ID: 19100412
    [Abstract] [Full Text] [Related]

  • 4. New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine?
    Deleuze S, Garrigue V, Delmas S, Chong G, Swarcz I, Cristol JP, Mourad G.
    Transplant Proc; 2006 Sep; 38(7):2311-3. PubMed ID: 16980075
    [Abstract] [Full Text] [Related]

  • 5. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
    Bolin P, Shihab FS, Mulloy L, Henning AK, Gao J, Bartucci M, Holman J, First MR, OPTIMA Study Group.
    Transplantation; 2008 Jul 15; 86(1):88-95. PubMed ID: 18622283
    [Abstract] [Full Text] [Related]

  • 6. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D, Miquel R, Porrini E, Fernández A, González-Posada JM, Hortal L, Checa MD, Rodríguez A, García JJ, Rufino M, Torres A.
    Transplantation; 2007 Sep 27; 84(6):706-14. PubMed ID: 17893603
    [Abstract] [Full Text] [Related]

  • 7. Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients.
    Loh PT, Lou HX, Zhao Y, Chin YM, Vathsala A.
    Transplant Proc; 2008 Jun 27; 40(5):1690-5. PubMed ID: 18589174
    [Abstract] [Full Text] [Related]

  • 8. Steroid-related complications in the cyclosporine era.
    Fryer JP, Granger DK, Leventhal JR, Gillingham K, Najarian JS, Matas AJ.
    Clin Transplant; 1994 Jun 27; 8(3 Pt 1):224-9. PubMed ID: 8061360
    [Abstract] [Full Text] [Related]

  • 9. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 10. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.
    Sato T, Inagaki A, Uchida K, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Tominaga Y, Okajima Y, Ohta K, Suga H, Taguchi S, Kakiya S, Itatsu T, Kobayashi T, Nakao A.
    Transplantation; 2003 Nov 15; 76(9):1320-6. PubMed ID: 14627910
    [Abstract] [Full Text] [Related]

  • 11. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.
    Hoitsma AJ, Hilbrands LB.
    Clin Transplant; 2006 Nov 15; 20(5):659-64. PubMed ID: 16968494
    [Abstract] [Full Text] [Related]

  • 12. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation.
    Vincenti F, Rostaing L, DIRECT (Diabetes Incidence after REnal Transplantation: Neoral C2 monitoring versus Tacrolimus) investigators.
    Contemp Clin Trials; 2005 Feb 15; 26(1):17-24. PubMed ID: 15837449
    [Abstract] [Full Text] [Related]

  • 13. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
    Porrini E, Delgado P, Alvarez A, Cobo M, Pérez L, González-Posada JM, Hortal L, Gallego R, García JJ, Checa M, Morales A, Salido E, Hernández D, Torres A.
    Nephrol Dial Transplant; 2008 Apr 15; 23(4):1436-41. PubMed ID: 18029372
    [Abstract] [Full Text] [Related]

  • 14. Immediate conversion from tacrolimus to cyclosporine in the treatment of posttransplantation diabetes mellitus.
    Oberholzer J, Thielke J, Hatipoglu B, Testa G, Sankary HN, Benedetti E.
    Transplant Proc; 2005 Mar 15; 37(2):999-1000. PubMed ID: 15848603
    [Abstract] [Full Text] [Related]

  • 15. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
    Hoyer PF, Brodeh J.
    J Am Soc Nephrol; 2006 Apr 15; 17(4):1151-7. PubMed ID: 16540560
    [Abstract] [Full Text] [Related]

  • 16. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients.
    Chang HR, Lin CC, Lian JD.
    Transplant Proc; 2007 Dec 15; 39(10):3135-41. PubMed ID: 18089339
    [Abstract] [Full Text] [Related]

  • 17. Posttransplant diabetes mellitus after kidney transplantation with different immunosuppressive agents.
    Romagnoli J, Citterio F, Violi P, Nanni G, Castagneto M.
    Transplant Proc; 2004 Apr 15; 36(3):690-1. PubMed ID: 15110632
    [Abstract] [Full Text] [Related]

  • 18. A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients.
    Kim SJ, Prasad GV, Huang M, Nash MM, Famure O, Park J, Thenganatt MA, Chowdhury N, Cole EH, Fenton SS, Cattran DC, Zaltzman JS, Cardella CJ.
    Transplantation; 2006 Oct 15; 82(7):924-30. PubMed ID: 17038908
    [Abstract] [Full Text] [Related]

  • 19. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
    Opelz G, Döhler B, Collaborative Transplant Study.
    Transplantation; 2009 Mar 27; 87(6):795-802. PubMed ID: 19300179
    [Abstract] [Full Text] [Related]

  • 20. Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens.
    Law YM, Yim R, Agatisa P, Boyle GJ, Miller SA, Lawrence K, Webber SA.
    J Heart Lung Transplant; 2006 Mar 27; 25(3):276-82. PubMed ID: 16507419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.